BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 10942797)

  • 1. Analysis of the p16INK4, p14ARF, p15, TP53, and MDM2 genes and their prognostic implications in osteosarcoma and Ewing sarcoma.
    Tsuchiya T; Sekine K; Hinohara S; Namiki T; Nobori T; Kaneko Y
    Cancer Genet Cytogenet; 2000 Jul; 120(2):91-8. PubMed ID: 10942797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of the p15, p16,and p18 genes in osteosarcoma.
    Miller CW; Aslo A; Campbell MJ; Kawamata N; Lampkin BC; Koeffler HP
    Cancer Genet Cytogenet; 1996 Feb; 86(2):136-42. PubMed ID: 8603340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course.
    Watanabe T; Katayama Y; Yoshino A; Komine C; Yokoyama T
    Clin Cancer Res; 2003 Oct; 9(13):4884-90. PubMed ID: 14581362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the p16INK4 and TP53 tumor suppressor genes in bone sarcoma pediatric patients.
    Patiño-García A; Sierrasesúmaga L
    Cancer Genet Cytogenet; 1997 Oct; 98(1):50-5. PubMed ID: 9309118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of the p53, Rb and MDM2 genes in osteosarcoma.
    Miller CW; Aslo A; Won A; Tan M; Lampkin B; Koeffler HP
    J Cancer Res Clin Oncol; 1996; 122(9):559-65. PubMed ID: 8781571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p16INK4 and p15INK4B alterations in primary gynecologic malignancy.
    Wong YF; Chung TK; Cheung TH; Nobori T; Yim SF; Lai KW; Phil M; Yu AL; Diccianni MB; Li TZ; Chang AM
    Gynecol Oncol; 1997 May; 65(2):319-24. PubMed ID: 9159345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of mutant p53 and c-erbB-2 proteins and mutations of the p15 and p16 genes in human gastric carcinoma: with respect to histological subtypes and stages.
    Wu MS; Shun CT; Sheu JC; Wang HP; Wang JT; Lee WJ; Chen CJ; Wang TH; Lin JT
    J Gastroenterol Hepatol; 1998 Mar; 13(3):305-10. PubMed ID: 9570245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of INK4A and INK4B genes in adult soft tissue sarcomas: effect on survival.
    Orlow I; Drobnjak M; Zhang ZF; Lewis J; Woodruff JM; Brennan MF; Cordon-Cardo C
    J Natl Cancer Inst; 1999 Jan; 91(1):73-9. PubMed ID: 9890173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and epigenetic alterations of the cell cycle regulators and tumor suppressor genes in pediatric osteosarcomas.
    Patiño-García A; Piñeiro ES; Díez MZ; Iturriagagoitia LG; Klüssmann FA; Ariznabarreta LS
    J Pediatr Hematol Oncol; 2003 May; 25(5):362-7. PubMed ID: 12759621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of p53, MDM2 and H-ras genes in low-grade central osteosarcoma.
    Park HR; Jung WW; Bertoni F; Bacchini P; Park JH; Kim YW; Park YK
    Pathol Res Pract; 2004; 200(6):439-45. PubMed ID: 15310147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors.
    Kovar H; Jug G; Aryee DN; Zoubek A; Ambros P; Gruber B; Windhager R; Gadner H
    Oncogene; 1997 Oct; 15(18):2225-32. PubMed ID: 9393981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma.
    Sonoda Y; Yoshimoto T; Sekiya T
    Oncogene; 1995 Nov; 11(10):2145-9. PubMed ID: 7478535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: a report from the Children's Oncology Group.
    Lerman DM; Monument MJ; McIlvaine E; Liu XQ; Huang D; Monovich L; Beeler N; Gorlick RG; Marina NM; Womer RB; Bridge JA; Krailo MD; Randall RL; Lessnick SL;
    Pediatr Blood Cancer; 2015 May; 62(5):759-65. PubMed ID: 25464386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic significance of p16INK4a/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia.
    Faderl S; Kantarjian HM; Manshouri T; Chan CY; Pierce S; Hays KJ; Cortes J; Thomas D; Estrov Z; Albitar M
    Clin Cancer Res; 1999 Jul; 5(7):1855-61. PubMed ID: 10430092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligodendroglial tumors frequently demonstrate hypermethylation of the CDKN2A (MTS1, p16INK4a), p14ARF, and CDKN2B (MTS2, p15INK4b) tumor suppressor genes.
    Wolter M; Reifenberger J; Blaschke B; Ichimura K; Schmidt EE; Collins VP; Reifenberger G
    J Neuropathol Exp Neurol; 2001 Dec; 60(12):1170-80. PubMed ID: 11764089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular analysis of tumor suppressor genes p16INK4 and TP53 of osteosarcomas in Spanish children].
    Patiño García A; Sierrasesúmaga Ariznabarreta L
    An Esp Pediatr; 1997 Nov; 47(5):478-82. PubMed ID: 9586287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent p16INK4 (MTS1) gene inactivation in testicular germ cell tumors.
    Chaubert P; Guillou L; Kurt AM; Bertholet MM; Metthez G; Leisinger HJ; Bosman F; Shaw P
    Am J Pathol; 1997 Sep; 151(3):859-65. PubMed ID: 9284835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status.
    Flørenes VA; Maelandsmo GM; Forus A; Andreassen A; Myklebost O; Fodstad O
    J Natl Cancer Inst; 1994 Sep; 86(17):1297-302. PubMed ID: 8064888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of p16 and p15 tumor suppressor genes and replication errors contribute independently to the pathogenesis of sporadic malignant melanoma.
    Matsumura Y; Nishigori C; Yagi T; Imamura S; Takebe H
    Arch Dermatol Res; 1998 Apr; 290(4):175-80. PubMed ID: 9617435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 gene mutation and ink4a-arf deletion appear to be two mutually exclusive events in human glioblastoma.
    Fulci G; Labuhn M; Maier D; Lachat Y; Hausmann O; Hegi ME; Janzer RC; Merlo A; Van Meir EG
    Oncogene; 2000 Aug; 19(33):3816-22. PubMed ID: 10949938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.